Publication | Open Access
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas
73
Citations
20
References
2016
Year
In head and neck cancer patients, nephrotoxicity grade 2 is under-reported but is the major factor for discontinuing cisplatin during CCRT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1